Inotiv Inc

NASDAQ:NOTVUnited States

Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Contact Information

Headquarters

2701 Kent AveWEST LAFAYETTE, IN, United States 47906-1350

Phone

317-463-4527

Fax

765-497-1102

Executives

Independent Chairman of the Board

Gregory Davis

President, Chief Executive Officer, Director

Robert Leasure

Chief Financial Officer, Senior Vice President - Finance

Beth Taylor

Chief Operating Officer

John Beattie

Senior Vice President, General Counsel, Corporate Secretary

Andrea Castetter